Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Deciphera Pharmaceuticals, Inc. Common Stock (DCPH)

Pharmaceutical Preparations

https://www.deciphera.com

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.

200 SMITH STREET
WALTHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/28/2017

Market Cap

2,212,920,840

Shares Outstanding

80,120,000

Weighted SO

80,123,138

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

EGRX --.--%

ANIP --.--%

PAHC --.--%

PBH --.--%

EVO --.--%

SUPN --.--%

SUPN --.--%

COLL --.--%

COLL --.--%

Beta

0.1840

Last Div

0.0000

Range

9.9-25.61

Chg

0.0200

Avg Vol

1855995

Mkt Cap

2212920840

Exch

NASDAQ

Country

US

Phone

781 209 6400

DCF Diff

0.0992

DCF

17.2108

Div Yield

0.0000

P/S

12.6518

EV Multiple

-10.5270

P/FV

7.0757

Div Yield %

0.0000

P/E

-11.7441

PEG

-3.4792

Payout

0.0000

Current Ratio

4.1944

Quick Ratio

3.6583

Cash Ratio

1.0935

DSO

68.2046

DIO

1111.3826

Op Cycle

1179.5872

DPO

1025.0447

CCC

154.5424

Gross Margin

0.9604

Op Margin

-1.1809

Pretax Margin

-1.0862

Net Margin

-1.0887

Eff Tax Rate

0.0002

ROA

-0.4524

ROE

-0.5242

ROCE

-0.6120

NI/EBT

1.0023

EBT/EBIT

0.9198

EBIT/Rev

-1.1809

Debt Ratio

0.0594

D/E

0.0792

LT Debt/Cap

0.0636

Total Debt/Cap

0.0734

Int Coverage

-56.6195

CF/Debt

-6.0675

Equity Multi

1.3318

Rec Turnover

5.3515

Pay Turnover

0.3561

Inv Turnover

0.3284

FA Turnover

4.8478

Asset Turnover

0.4155

OCF/Share

-1.7374

FCF/Share

-1.7438

Cash/Share

3.1186

OCF/Sales

-0.8680

FCF/OCF

1.0037

CF Coverage

-6.0675

ST Coverage

-42.4810

CapEx Coverage

-269.1968

Div&CapEx Cov

-269.1968

P/BV

7.0757

P/B

7.0757

P/S

12.6518

P/E

-11.7441

P/FCF

-14.5213

P/OCF

-14.7290

P/CF

-14.7290

PEG

-3.4792

P/S

12.6518

EV Multiple

-10.5270

P/FV

7.0757

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 20, 14:00 What 4 Analyst Ratings Have To Say About Deciphera Pharmaceuticals Benzinga Nov 20, 14:00 What 4 Analyst Ratings Have To Say About Deciphera Pharmaceuticals

Revenue Product Segmentation